Literature DB >> 25561792

Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.

Xu Liu1, Ayako Hakucho1, Jinyao Liu1, Tatsuya Fujimiya1.   

Abstract

AIM: To investigate ethanol-induced hepatic steatosis after liver resection and the mechanisms behind it.
METHODS: First, the preliminary examination was performed on 6 sham-operated (Sham) and 30 partial hepatectomy (PH) male Wistar rats (8-wk-old) to evaluate the recovery of the liver weight and liver function after liver resection. PH rats were sacrificed at the indicated time points (4, 8, and 12 h; 1, 3, and 7 d) after PH. Second, the time point for the beginning of the chronic ethanol exposure (1 wk after sham- or PH-operation) was determined based on the results of the preliminary examination. Finally, pair-feeding was performed with a controlled diet or with a 5-g/dL ethanol liquid diet for 28 d in another 35 age-matched male Wistar rats with a one-week recovery after undergoing a sham- (n = 15) or PH-operation (n = 20) to evaluate the ethanol-induced liver injury after liver resection. Hepatic steatosis, liver function, fatty acid synthase (Fas) gene expression level, the expression of lipid metabolism-associated enzyme regulator genes [sterol regulatory element binding protein (Srebp)-1 and peroxisome proliferator-activated receptor (Ppar)-α], the mediators that alter lipid metabolism [plasminogen activator (Pai)-1 gene expression level and tumor necrosis factor (Tnf)-α production], and hepatic class-1 alcohol dehydrogenase (Adh1)-associated ethanol elimination were investigated in the 4 groups based on histological, immunohistochemical, biochemical, Western blotting, reverse transcriptase chain reaction, and blood ethanol concentration analyses. The relevant gene expression levels, liver weight, and liver function were assessed before and 1 wk after surgery to determine the subject's recovery from the liver resection using the rats that had been subjected to the preliminary examination.
RESULTS: In the PH rats, ethanol induced marked hepatic steatosis with impaired liver functioning, as evidenced by the accumulation of fatty droplets within the hepatocytes, the higher increases in their hepatic triglyceride and blood alanine aminotransferase and blood aspartate aminotransferase levels after the 28-d pair-feeding period. The Sham-ethanol rats, not the PH-ethanol rats, demonstrated the up-regulation of Srebp-1 and the down-regulation of Ppar-α mRNA expression levels after the 28-d pair-feeding period. The 28-d ethanol administration induced the up-regulation of Pai-1 gene expression level and an overproduction of TNF-α in the Sham and the PH rats; however, the effect was more significant in the PH rats. The PH-ethanol rats (n = 4) showed higher residual blood ethanol concentrations than did the Sham-ethanol rats (n = 6) after a 5-h fast (0.66 ± 0.4 mg/mL vs 0.2 ± 0.1 mg/mL, P < 0.05); these effects manifested without up-regulation of Adh1 gene expression, which was present in the Sham-ethanol group after the 28-d pair-feeding period. One week after the liver resection, the liver weight, function, the gene expression levels of Fas, Srebp-1, Ppar-α, Pai-1 and Tnf-α recovered; however, the Adh1 gene expression did not recover in rats.
CONCLUSION: Desensitization to post-hepatectomy ethanol treatment and slow recovery from PH in Adh1 gene expression enhanced the susceptibility to ethanol-induced hepatic steatosis after PH in rats.

Entities:  

Keywords:  Ethanol; Ethanol elimination; Hepatic class-1 alcohol dehydrogenase; Hepatic steatosis; Liver function; Liver resection

Mesh:

Substances:

Year:  2014        PMID: 25561792      PMCID: PMC4277962          DOI: 10.3748/wjg.v20.i48.18249

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Genetic polymorphisms in ethanol metabolism: issues and goals for physiologically based pharmacokinetic modeling.

Authors:  G M Pastino; E J Flynn; L G Sultatos
Journal:  Drug Chem Toxicol       Date:  2000-02       Impact factor: 3.356

2.  Purification and molecular properties of urate oxidase from Chlamydomonas reinhardtii.

Authors:  J M Alamillo; J Cárdenas; M Pineda
Journal:  Biochim Biophys Acta       Date:  1991-01-29

Review 3.  Plasminogen activator inhibitors--a review.

Authors:  E K Kruithof
Journal:  Enzyme       Date:  1988

Review 4.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

5.  Dietary oxidized fat prevents ethanol-induced triacylglycerol accumulation and increases expression of PPARalpha target genes in rat liver.

Authors:  Robert Ringseis; Alexandra Muschick; Klaus Eder
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

Review 6.  Does living donation have advantages over deceased donation in liver transplantation?

Authors:  Toshimi Kaido; Shinji Uemoto
Journal:  J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 4.029

7.  The effect of ethanol on the beta-oxidation of fatty acids.

Authors:  N Grunnet; J Kondrup
Journal:  Alcohol Clin Exp Res       Date:  1986       Impact factor: 3.455

8.  Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.

Authors:  Marie-Christine Alessi; Delphine Bastelica; Alenka Mavri; Pierre Morange; Bruno Berthet; Michel Grino; Irene Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-15       Impact factor: 8.311

9.  PAI-1 plays an important role in liver failure after excessive hepatectomy in the rat.

Authors:  Kazuteru Watanabe; Shinji Togo; Takuji Takahashi; Ryusei Matsuyama; Harumi Yamamoto; Tetsuya Shimizu; Hirochika Makino; Kenichi Matsuo; Daisuke Morioka; Toru Kubota; Yoji Nagashima; Hiroshi Shimada
Journal:  J Surg Res       Date:  2007-07-26       Impact factor: 2.192

10.  Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1.

Authors:  V Nachiappan; D Curtiss; B E Corkey; L Kilpatrick
Journal:  Shock       Date:  1994-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.